Christopher Rodman
发表
C. Rodman,
A. Atala,
G. Almeida-Porada,
2014,
Front. Pharmacol..
Charles H. Yoon,
A. Regev,
P. Sorger,
2016,
Science.
Maria K. Lehtinen,
Frederick B. Shipley,
A. Regev,
2021,
Cell.
Maria K. Lehtinen,
Frederick B. Shipley,
A. Regev,
2019,
bioRxiv.
Monika S. Kowalczyk,
A. Regev,
P. Sorger,
2018,
Cell.
Shawn M. Gillespie,
A. Regev,
B. Bernstein,
2017,
Cell.
Martin J. Aryee,
Jason D. Buenrostro,
Jacob C. Ulirsch,
2019,
Cell.
Mariella G. Filbin,
McKenzie L. Shaw,
Shawn M. Gillespie,
2017,
Science.
Mariella G. Filbin,
McKenzie L. Shaw,
Lisa Mayr,
2019,
Cell.
James M. McFarland,
A. Regev,
Hadas Keren-Shaul,
2020,
Nature Genetics.
A. Regev,
T. Brinker,
P. Sorger,
2020,
Nature Medicine.
A. Regev,
X. Zhuang,
I. Tirosh,
2021,
Cancer cell.
C. Rodman,
S. Soker,
A. Atala,
2015,
Annals of Biomedical Engineering.
C. Rodman,
A. Atala,
G. Almeida-Porada,
2021,
Frontiers in Cell and Developmental Biology.
Monika S. Kowalczyk,
Timothy L. Tickle,
B. Haas,
2017,
Nature.
Mariella G. Filbin,
Jonathan M. Fisher,
Maristela L Onozato,
2016,
Nature.
James M. McFarland,
Bender,
A. Regev,
2019
.
Abstract PR01: A cancer cell program promotes T-cell exclusion and resistance to checkpoint blockade
A. Regev,
C. Rodman,
P. Shah,
2020,
Cancer Research.